Thymosin Alpha-1 (T?1) is a synthetic 28-amino acid peptide corresponding to the N-terminal fragment of prothymosin alpha, naturally produced by thymic epithelial cells. It plays a central role in T-cell maturation and immune system modulation. Originally isolated by Allan Goldstein and colleagues in the 1970s during seminal research into thymic factors and their role in immune competence.
Researchers have extensively studied Thymosin Alpha-1 for its immunomodulatory properties, particularly its effects on T-cell differentiation and activation. Studies have examined its ability to promote maturation of T-cell precursors and enhance the expression of T-cell surface markers. Research has explored its effects on dendritic cell function and the polarization of T-helper cell responses, including its influence on Th1 versus Th2 balance in immune models.
Preclinical and clinical research has examined Thymosin Alpha-1 in models of immune deficiency, chronic viral infection, and cancer immunology. Studies have explored its ability to enhance natural killer (NK) cell activity and augment cytotoxic T-lymphocyte responses. Research has also investigated its effects on toll-like receptor signaling and its potential anti-inflammatory properties through modulation of pro-inflammatory cytokine production. Its well-characterized immune biology has made it one of the most studied thymic peptides in immunological research.
For research use only. Not for human consumption. Iron Prairie Labs products are intended for qualified researchers and laboratory use only.
